PESI · Perma Fix Environmental Services Inc
$16.64
+0.96 (+6.12%)
At close · Jul 28
Going-concern doubt
— flagged May 7, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events, when considered in the aggregate, raise substantial doubt about the Company's ability to continue as a going concern within one year after the date these financial statements are issued.”View the 10-Q filed May 7, 2026
Market Cap
$308.91M
Shares
18.56M
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Troy Eshleman | COO | $624,131 |
| Mark Duff | CEO | $453,081 |
| Ben Naccarato | CFO | $392,185 |
| Richard Grondin | EVP of Waste Treatment Operations; Member of the Supervisory Board of PF Medical | $359,682 |
| Dr. Louis Centofanti | EVP of Strategic Initiatives | $308,552 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Mark Duff | CEO | $456,461 |
| Ben Naccarato | CFO | $385,170 |
| Richard Grondin | EVP of Waste Treatment Operations; Member of the Supervisory Board of PF Medical | $326,597 |
| Dr. Louis Centofanti | EVP of Strategic Initiatives | $306,256 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Mark Duff | CEO | $748,095 |
| Ben Naccarato | CFO | $595,477 |
| Andy Lombardo | EVP of Nuclear & Technical Services | $589,825 |
| Richard Grondin | EVP of Waste Treatment Operations; Member of the Supervisory Board of PF Medical | $498,325 |
| Dr. Louis Centofanti | EVP of Strategic Initiatives | $485,425 |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Mark Duff | CEO | $416,140 |
| Ben Naccarato | CFO | $356,256 |
| Andy Lombardo | EVP of Nuclear & Technical Services | $319,860 |
| Richard Grondin | EVP of Waste Treatment Operations; Member of the Supervisory Board of PF Medical | $299,473 |
| Dr. Louis Centofanti | EVP of Strategic Initiatives | $292,756 |
Fiscal 2021
| Executive | Role | Total |
|---|---|---|
| Mark Duff | CEO | $562,980 |
| Ben Naccarato | CFO | $418,029 |
| Andy Lombardo | EVP of Nuclear & Technical Services | $388,089 |
| Richard Grondin | EVP of Waste Treatment Operations; Member of the Supervisory Board of PF Medical | $365,842 |
| Dr. Louis Centofanti | EVP of Strategic Initiatives | $343,404 |
Fiscal 2020
| Executive | Role | Total |
|---|---|---|
| Mark Duff | CEO | $508,340 |
| Ben Naccarato | CFO | $407,594 |
| Andy Lombardo | EVP of Nuclear & Technical Services | $402,385 |
| Dr. Louis Centofanti | EVP of Strategic Initiatives | $338,784 |
| Richard Grondin | EVP of Waste Treatment Operations; Member of the Supervisory Board of PF Medical | $323,510 |
Fiscal 2019
| Executive | Role | Total |
|---|---|---|
| Mark Duff | CEO | $462,943 |
| Ben Naccarato | CFO | $378,500 |
| Andy Lombardo | EVP of Nuclear & Technical Services | $367,202 |
| Dr. Louis Centofanti | EVP of Strategic Initiatives | $361,505 |
| Richard Grondin | EVP of Waste Treatment Operations; Member of the Supervisory Board of PF Medical | $257,607 |
Fiscal 2018
| Executive | Role | Total |
|---|---|---|
| Mark Duff | CEO | $304,680 |
| Ben Naccarato | CFO | $270,226 |
| Andy Lombardo | EVP of Nuclear & Technical Services | $257,400 |
| Dr. Louis Centofanti | EVP of Strategic Initiatives | $255,577 |
Key facts
CIK
891532
CUSIP
714157203
13F (30d)
10 filings
10 filers
Visit website
Investor relations